HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Howard K. Song Karl F. Welke Fred Edwards Ross M. Ungerleider Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Song, H. K. Articles by Ungerleider, R. M. Search for Related Content PubMed PubMed Citation Articles by Song, H. K. Articles by Ungerleider, R. M. Related Collections Valve disease

---

Original Articles: Adult Cardiac

Gender Differences in Mortality After Mitral Valve Operation: Evidence for Higher Mortality in Perimenopausal Women

^a The Division of Cardiothoracic Surgery, Oregon Health & Science University, Portland, Oregon
^b Duke Clinical Research Institute, Duke University, Durham, North Carolina
^c Division of Cardiothoracic Surgery, University of Florida College of Medicine, Jacksonville, Florida

Accepted for publication February 27, 2008.

^_* Address correspondence to Dr Song, Division of Cardiothoracic Surgery, Oregon Health & Science University, Mail Code L353, 3181 SW Sam Jackson Park Rd, Portland, OR 97239 (Email: songh{at}ohsu.edu).

Presented at the Fifty-fourth Annual Meeting of the Southern Thoracic Surgical Association, Bonita Springs, FL, Nov 7–10, 2007.

Background: Hormonal status is a potentially important cause for gender differences in outcomes after cardiovascular operations. Estrogen withdrawal states may potentiate ischemia–reperfusion injury by impairing endothelial cell function and increasing inflammatory cytokine levels. We hypothesized that gender influences mortality after mitral valve operations and that it varies with age, especially during periods of declining ovarian function.

Methods: We studied 24,977 patients (49% women) in The Society of Thoracic Surgeons National Database who underwent isolated mitral valve repair or replacement from 2002 to 2005. Age-related gender differences in mortality after mitral valve operation were compared by risk-adjusted analysis.

Results: Gender and age had a pronounced impact on hospital mortality. Women aged 40 to 49 and 50 to 59 had significantly greater hospital mortality than risk-matched men. The adjusted female/male odds ratio for hospital mortality in the group aged 40 to 49 was 2.56 (95% confidence interval, 1.31 to 5.01) but progressively decreased in the four subsequent age groups. This pattern was statistically significant (p = 0.028 and p = 0.018 for 40 to 49 vs 70 to 79 and 80 to 89, respectively) and represents a declining relative mortality risk for women of advanced age.

Conclusions: In patients aged 40 to 59 years, the mortality of mitral valve operation is approximately 2.5 times higher in women compared with men with similar risk factors. This survival disadvantage diminishes with further aging. Changes in ovarian function may be an important cause for this gender–age interaction and are a potential target for novel hormone-based therapies.

This article has been cited by other articles:

				S. H. Rahimtoola The Year in Valvular Heart Disease J. Am. Coll. Cardiol., May 19, 2009; 53(20): 1894 - 1908. [Full Text] [PDF]

				K. Spiliopoulos, A. Haschemi, P. Parasiris, and B. M. Kemkes Sorin BicarbonTM bileaflet valve: a 9.8-year experience. Clinical performance of the prosthesis after heart valve replacement in 587 patients Interactive CardioVascular and Thoracic Surgery, February 1, 2009; 8(2): 252 - 259. [Abstract] [Full Text] [PDF]